Biopharma Layoff Tracker 2024. 2023 was a year of economic uncertainty for the biotech industry, which led to a funding drought. Allakos inc is ending work on its candidate lirentelimab and laying off 50% of its workforce, c4 therapeutics, inc.
[ updated on april 10, 2024 ] the biotech sector. The median round of biotech layoffs this year involved about 40 employees, although at.
The Biotech Is Laying Off About 29% Of Its Employees And Will Focus Its Resources On The Company’s Hypoimmune Platform.
[ april 4, 2024 ] biopharma layoff tracker 2024:
Carisma, Omega, Xilio And More Cut Staff Biospace [ April 4, 2024 ] Nanostring Products Drive Breakthrough Cancer.
— albeit at a slightly lower clip than in 2023.
The Median Round Of Biotech Layoffs This Year Involved About 40 Employees, Although At.
Images References :
Allakos Inc Is Ending Work On Its Candidate Lirentelimab And Laying Off 50% Of Its Workforce, C4 Therapeutics, Inc.
After 10% of the #workforce was laid off in a wave of layoffs, the #biotech company partnered with vertex pharmaceuticals has revealed its most recent internal #changes: